Age-related diseases such as AMD appear to be particularly suited for NRF2 modulation since there is evidence that NRF2 activity declines with aging [85,95] and that there is NRF2 involvement in most of the hallmarks of aging [84]. Here, NFE2L2 is linked to age-related macular degeneration.